REFERENCES
1. Vedel AG, Holmgaard F, Rasmussen LS, Paulson OB, Thomsen C, Danielsen ER, Langkilde A, Goetze JP, Lange T, Ravn HB, Nilsson JC. Perfusion Pressure Cerebral Infarct (PPCI) trial - the importance of mean arterial pressure during cardiopulmonary bypass to prevent cerebral complications after cardiac surgery: study protocol for a randomised controlled trial. Trials. 2016 May 17;17(1):247
2 . Chai X, Hu L, Zhang Y, Han W, Lu Z, Ke A, et al. Specific ACE2 expression in cholangiocytes may cause liver damage after 2019-nCoV infection. BioRxiv 2020.
3. Furong Liu , Xin Long Bixiang Zhang ,Wanguang Zhang Xiaoping Chen , Zhanguo Zhang ,ACE2 Expression in Pancreas May Cause Pancreatic Damage After SARS-CoV-2 Infection Clin Gastroenterol Hepatol 2020 Aug;18(9):2128-2130.e2.
4. Yang JK, Feng Y, Yuan MY, et al. Plasma glucose levels and diabetes are independent predictors for mortality and morbidity in patients with SARS. Diabet Med 2006;23(6):623–628.
5. Yang JK, Lin SS, Ji XJ, et al. Binding of SARS coronavirus to its receptor damages islets and causes acute diabetes. Acta Diabetol2010;47:193–199
6. James P. Corsetti, Christopher Cox, Thadeus J. Schlz, and Dean A. Arvan (1993). Combined Serum Amylase and Lipase Deteriminations for Diagnosis of Suspected. CLIN CHEM. 39/12, 2495-2499.
7. P. A. Banks, T. L. Bollen, C. Dervenis et al.,“Classification of acute pancreatitis 2012: revision of the Atlanta classification and definitions by international consensus,” Gut,vol.62, no.1 pp. 102–111, 2013.
8. Clinical management of COVID-19. WHO interim guidance. COVID-19: Clinical care. 2020. https ://www.who.int/publi catio ns/i/item/clini cal-manag ement -of-covid -19.
9. Johnson CD, Abu-Hilal M. Persistent organ failure during the first week as a marker of fatal outcome in acute pancreatitis. Gut 2004;53:1340–4.
10. Mofidi R, Duff MD, Wigmore SJ, et al. Association between early systemic inflammatory response, severity of multiorgan dysfunction and death in acute pancreatitis. The British journal of surgery 2006;93:738–44.
11. Jothimani D, Venugopal R, Abedin MF, Kaliamoorthy I, Rela M. COVID-19 and Liver. J Hepatol 2020.
12. EASL. EASL clinical practice guidelines: drug-induced liver injury. J Hepatol. 2019;70:1222–611.
13 . Ricci Z, Cruz D, Ronco C. The RIFLE criteria and mortality in acute kidney injury: a systematic review. Kidney Int 2008;73: 538–46
14. Bruno G, Fabrizio C, Santoro CR, Buccoliero GB. Pancreatic injury in the course of coronavirus disease 2019 (COVID-19): a not-so-rare occurrence. J Med Virol 2020.
15. McNabb-Baltar J, Jin DX, Grover AS, Redd WD, Zhou JC, Hathorn KE, et al. Lipase elevation in patients with COVID-19. Am J Gastroenterol 2020. https://
16. Wang F, Wang H, Fan J, Zhang Y, Wang H, Zhao Q. Pancreatic injury patterns in patients with coronavirus disease 19 pneumonia. Gastroenterology 2020.
17. Barlass U, Wiliams B, Dhana K, Adnan D, Khan SR, Mahdavinia M, et al. Marked elevation of lipase in COVID-19 disease: a cohort study. Clin Transl Gastroenterol 2020;11:e00215.
18. Lax SF, Skok K, Zechner P, Kessler HH, Kaufmann N, Koelblinger C, et al. Pulmonary arterial thrombosis in COVID-19 with fatal outcome: results from a prospective, single-center, clinicopathologic case series. Ann Intern Med 2020.
19. Hanley B, Naresh KN, Roufosse C, Nicholson AG, Weir J, Cooke GS, et al. Histopathological findings and viral tropism in UK patients with severe fatal COVID-19: a post-mortem study. Lancet Microbe 2020.
20. Rabice SR, Altshuler PC, Bovet C, Sullivan C, Gagnon AJ. COVID-19 infection presenting as pancreatitis in a pregnant woman: a case report. Case Rep Womens Health 2020;27:e00228.
21. Cheung S, Delgado Fuentes A, Fetterman AD. Recurrent acute pancreatitis in a patient with COVID-19 infection. Am J Case Rep 2020;21:e9270